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 Coronary artery disease (CAD) is a disease characterized by 
atherosclerotic plaque formation in the epicardial coronary arteries.1,2 It 
is well known as the leading cause of mortality around the world.2,3 
Annually, in Indonesia, at least 470,000 mortalities are estimated to be 
caused by CAD or stroke.4 The various clinical presentations can be 
caused by the dynamic nature of CAD. Generally, according to the 
clinical presentation, CAD can be classified into chronic coronary 
syndromes (CCS) and acute coronary syndromes (ACS).1 CCS in a new 
terminology proposed by the European Society of Cardiology (ESC) 
replacing stable CAD. The CCS is defined as the progressive atheroscle-
rotic plaque accumulation process accompanied by functional 
alteration in the coronary artery. It has replaced the old terminology 
stable CAD.1 The management of CCS includes lifestyle changes, 
optimal medical treatment (OMT), and myocardial revascularization.1,5
 Myocardial revascularization strategies in CAD include 
percutaneous coronary intervention (PCI) and coronary artery bypass 
graft (CABG) surgery.6 The purpose of myocardial revascularization in 
CCS includes: (1) myocardial ischemia elimination; (2) eliminate 
clinical manifestations; and (3) major adverse cardiovascular event 
(MACE) risk reduction.1,5,6 Revascularization strategy by PCI or CABG 
can be determined using the Synergy Between PCI With Taxus and 
CABG (SYNTAX) score.6 
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Background : The benefit of PCI to improve quality of life (QoL) in chronic coronary syndrome (CCS) is still 
unclear. 
Objectives : This study aimed to assess the benefit of percutaneous coronary intervention (PCI) in improving QoL 
among CCS patients receiving OMT.
Methods : We conducted a retrospective cohort study. CCS patients who underwent coronary angiography (CAG) 
and/or PCI were grouped into OMT plus PCI and OMT groups. The SYNTAX score was used to assess the 
complexity and severity of coronary artery lesions. The outcome measured was QoL assessed using Seattle 
Angina Questionnaire (SAQ) and rehospitalization.
Results: A total of 57 patients in the OMT plus PCI group and 49 patients in the OMT group were included. The 
percentage of patients with good QoL was higher in the OMT plus PCI group than OMT only group (64.5% vs. 
35.5%; p = 0.007). The OMT plus PCI group revealed a better activities of daily living (85.11 ± 12.46 vs. 12.46 
± 21.87; p = 0.014) and angina stability (84.32 ± 23.63 vs. 71.81 ± 27.89; p = 0.014) than OMT group. Among 
patients with SYNTAX scores of more than 22, achievement of good QoL was greater in the OMT plus PCI group 
than the OMT group (80.8% vs. 45.5%; p = 0.025).
Conclusion: PCI improved the QoL in CCS patients treated with OMT. Second, OMT plus PCI improves physical 
limitation and angina stability. For patients with a SYNTAX score of more than 22, OMT plus PCI was correlated 
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 Basically, the SYNTAX score is the assessment tool to 
evaluate the severity or complexity of coronary artery lesions.7,8 Until 
now, the superiority of OMT plus PCI versus OMT alone based on the 
SYNTAX score in quality of life (QoL) of CCS patients is still unclear. 
Therefore, this study purposed to evaluate the benefit of PCI in improv-




2.1. Study design participants
 A retrospective cohort study was completed in dr. Saiful 
Anwar General Hospital Malang, East Java, Indonesia in 2016. This 
research was approved by the ethical review board and conformed with 
the principles of the declaration of Helsinki. Before conducting data 
collection, patients or their family members had signed the informed 
consent. 
 We identified patients who had undergone coronary angiog-
raphy (CAG) and/or PCI from the registry database in the catheteriza-
tion laboratory of dr. Saiful Anwar General Hospital. The inclusion 
criteria include: (1) CCS patients receiving OMT; (2) good compliance 
to the medical treatment; (3) underwent CAG and had at least 50% 
stenosis in one or more coronary arteries; and (4) aged more than 40 
years old. Patients were excluded because of these reasons: (1) lost to 
follow-up; (2) psychiatric disorders; and/or (3) disability to conduct 
physical activities. Patients were classified into “OMT plus PCI group” 
and “OMT group.” All important information about demographic data, 
cardiovascular diseases (CVD) risk factors, comorbid diseases, echocar-
diographic parameters, and treatment regimen were obtained from the 
direct interview and medical record.  
2.2. SYNTAX Score assesment
 
 SYNTAX Score was assessed by carefully reading the 
coronary angiogram. The calculation of the SYNTAX score was 
completed using the online calculator. The variables of SYNTAX score 
include: (1) the dominant coronary artery; (2) number of coronary 
lesions; (3) segment involved; (4) total occlusion; (5) trifurcation; (6) 
bifurcation; (7) aorto-ostial lesion; (8) tortuosity; (9) lesion length; 
(10) calcification; (11) thrombus; and (12) diffuses disease.7,9 A total 
SYNTAX score of ≤22, 22-32, and ≥32 are categorized as mild, moder-
ate, and severe lesions, respectively.10  Two physicians conducted the 
SYNTAX score assessment. The discrepancy in the SYNTAX score 
assessment between the two investigators was resolved by the sugges-
tion from the third investigator.   
2.4. Outcome
 The outcomes assessed were QoL and rehospitalization 
assessed within 6 to 12 months following CAG and/or PCI. Outcome 
data were obtained from the direct interview or phone call. QoL was 
assessed using the Seattle Angina Questionnaire (SAQ). Variables 
measured in SAQ included activities of daily living (ADL), angina 
stability, angina frequency, treatment satisfaction, and disease percep-
tion.11 The SAQ >70 was classified as good QoL. On the other hand, 
patients were classified as having poor QoL if they had SAQ ≤70.
2.4. Stastitical Analysis 
 We used the IBM Statistical Package for Social Science (SPSS 
version 25.0) for the statistical analysis process. Mean and standard 
deviation (SD) were used to demonstrate the continuous data. Categor-
ical data were showed using the number and percentage. T-test and 
Mann Whitney test were used to compare continuous data with typical-
ly and not normally distributed data, respectively. The Chi-squared test 
and Fisher's exact test were used to compare categorical data. Statisti-
cally significant was considered if the p-value was less than 0.05.
3. Result 
3.1. Baseline characteristics
 Generally, both groups share similar baseline characteristics 
(p ≥0.05). Male predominated our study population, 83.1% and 74.5% 
for OMT plus PCI group and OMT group, respectively. The mean age 
was 58.88 ± 7.56 years old for OMT plus PCI group and 61.55 ± 8.55 
years old for the OMT group. In OMT plus PCI group, the most common 
CVD risk factor was hypertension (69%). While in the OMT group, 
dyslipidemia (64.4%) was the common CVD risk factor. Heart failure 
was the most common comorbid disease in OMT plus PCI group 
(36.8%) and the OMT group (57.4%). The baseline mean left ventricu-
lar ejection fraction (LVEF) was 48.72 ± 16.92 % in OMT plus PCI 
group and 50.50 ± 15.78% in the OMT group. All patients in both 
groups received antiplatelet and statin. The mean syntax score was 
19.7 ± 10 and 19.91 ± 12.98 for OMT plus PCI group and OMT group, 
respectively. SYNTAX score severity distribution between both groups 
was not significantly different (p = 0.155) (Table 1).
3.1. Clinical outcomes
 The mean follow-up duration of all patients was 7.8 ± 0.95 
months. The rehospitalization rate between OMT plus PCI group and 
the OMT group was not significantly different (16.9% vs. 17%; p = 
1.00). However, the percentage of patients with good QoL was higher 
in the OMT plus PCI group than OMT only group (64.5% vs. 35.5%; p 
= 0.007). We also performed subgroup analysis in each SAQ parame-
ter. The OMT plus PCI group revealed a better ADL (85.11 ± 12.46 vs. 
12.46 ± 21.87; p = 0.014) and angina stability (84.32 ± 23.63 vs. 
Figure 1. Good quality of life outcome among patients with SYNTAX 
score of more than 22. OMT = optimal medical treatment; PCI = 
percutaneous coronary intervention; SYNTAX = Synergy Between PCI 
With Taxus and CABG.
 
16
W. Karolina, et al. Heart Sci J 2021; 2(2): 15-20
71.81 ± 27.89; p = 0.014) than OMT group. However, the angina 
frequency (82.79 ± 20.75 vs. 73.43 ± 23.99; p = 0.033) and treatment 
satisfaction (82.77 ± 15.27 vs. 80.19 ± 16.24; p = 0.401) in both 
groups were not significantly different (Table 2).
 We also conducted a further subgroup analysis. In the OMT 
plus PCI group, the SYNTAX score in the patients who suffered from 
rehospitalization was not significantly different from those who did not 
suffer from rehospitalization (19.86 ± 9.50 vs. 18.90 ± 12.70; p = 
0.967). However, in this group, patients with good QoL revealed a 
lower SYNTAX score than patients with poor QoL (18.50 ± 9.07 vs. 
25.60 ± 12.63; p = 0.040).
 In the OMT group, the SYNTAX score between rehospitalized 
and non-rehospitalized patients was not significantly different (19.79 ± 
13.61 vs. 20.50 ± 12.92; p = 0.891). The SYNTAX score in good QoL 
and poor QoL patients was also not significantly different (17.51 ± 
12.07 vs. 23.15 ± 13.76; p = 0.143) (Table 2). Moreover, among 
patients with SYNTAX score of more than 22s, achievement of good 
QoL was greater in OMT plus PCI group than the OMT group (80.8% vs. 
45.5%; p = 0.025) (Figure 1). 
17
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Note, data were presented in mean ± SD or n(%); ACE = angiotensin-converting enzyme; ARBs = angiotensin receptor blockers; CABG = coronary artery bypass 
graft; CAD = coronary artery disease; CCBs = calcium channel blockers; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; CVD = 
cardiovascular diseases; LVEF = left ventricular ejection fraction; OMT = optimal medical treatment; PAD = peripheral artery disease; PCI = percutaneous 
coronary intervention; SS = SYNTAX score; SYNTAX = Synergy Between PCI With Taxus and CABG.
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4. Discussion
 Our study revealed several important findings. First, PCI 
could improve the QoL in CCS patients. Second, OMT plus PCI 
improved physical limitation and angina stability. The last, in patients 
with SYNTAX score of more than 22, OMT plus PCI was associated with 
good QoL achievement.
 The pathogenesis mechanisms in CCS start with atherosclero-
sis format ion, which develops and progress slowly for several decades. 
The several risk factors for CVD such as aging, diabetes mellitus, dyslip-
idemia, genetics, hypertension, obesity, or lack of physical activity will 
lead a low-grade inflammation and accelerate the atherosclerosis 
process. In CCS, this slow atherosclerotic plaque progression causes 
gradual thickening of the inner layer of the coronary arteries, which can 
narrow the arterial lumen in various severity.12 In most cases, the lesion 
severity evaluation is conducted using CAG. However, to determine the 
structure of the vessel wall and the morphology of atherosclerotic 
plaque, imaging tools such as intravascular ultrasound (IVUS) or 
optical coherence tomography (OCT) are needed.13,14 The blood flow 
restriction due to obstructive lesions in the coronary arteries cannot 
compensate for increased myocardial oxygen demand in certain 
conditions. This oxygen supply and demand mismatch leads to myocar-
dial ischemia.15,16 In general, if the lesion is greater than 80% of lumen 
diameter, compensatory vasodilatation will not be helpful. Vascular 
spasm or endothelial injury may increase the severity of stenosis due to 
atherosclerotic plaque.16 Current practice guidelines strongly recom-
mend lifestyle changes, OMT, and myocardial revascularization such as 
PCI or CABG as the backbone treatment of CCS.1,5
 Our study revealed that OMT plus PCI was associated with 
good QoL. Our results supported the findings from prior studies such as 
COURAGE trial and TIME trial. The COURAGE trial results gave us an 
important lesson that among CCS patients receiving OMT, PCI had 
small but significant advantages in improving QoL, especially in the 
three years following the PCI procedure.17 The TIME trial that included 
elderly patients aged ≥75 years old demonstrated that PCI and CABG 
improved the QoL and symptom relief. On the other hand, myocardial 
revascularization successfully reduced the incidence of MACE.18 
 
In the subgroup analysis of the SAQ, our results demonstrated that PCI 
was associated with better ADL and angina stability. In CCS, the under-
lying coronary lesion is the stable plaque with significant stenosis. The 
stable coronary plaque contains (1) low lipid accumulation; (2) greater 
smooth muscle cell; (3) more extracellular matrix; and (4) thick fibrous 
cap.19 When coronary artery stenosis reaches more than 80% of lumen 
diameter, adequate oxygen supply to the myocardial tissue cannot be 
provided.16 In this condition, PCI is reasonable because it can provide a 
wider vessel lumen diameter close to the normal vessel lumen diameter. 
Therefore, an adequate oxygen supply can be restored. Moreover, the 
balance between oxygen demand and oxygen supply can be achieved, 
and angina symptoms can be relieved. 
 SYNTAX score is the assessment tool to evaluate the severity 
or complexity of coronary artery lesions. A greater SYNTAX score 
indicates a more severe and more complex coronary lesion as well as 
poor prognosis in patients receiving PCI.7,8 In patients with complex 
lesions such as left main coronary artery disease or three-vessel disease, 
the SYNTAX score could predict the incidence of mortality or MACE.20,21  
Our studies revealed that patients with good QoL in the OMT plus PCI 
group revealed a lower SYNTAX score than patients with poor QoL. 
According to this finding, we could learn that PCI would be effective if 
applied in patients with low complexity of coronary lesions. Moreover, 
the current myocardial revascularization guideline strongly recom-
mends CABG over PCI for CCS patients with: (1) left main disease with 
moderate or high SYNTAX score; (2) three-vessel disease with diabetes 
mellitus; and (3) three-vessel disease with moderate or high SYNTAX 
score without diabetes mellitus. However, the recommendation for PCI 
is higher than CABG in one or two-vessel disease without proximal left 
anterior descending (LAD) stenosis.6 
 Our study also demonstrated that among patients with 
SYNTAX score of more than 22s, achievement of good QoL was greater 
in OMT plus PCI group than the OMT group. The higher the SYNTAX 
score is associated with, the more complex and the more severe 
coronary lesion.7,8 The ischemic burden and mortality risk also higher in 
those populations indeed.22 In those population, revascularization is the 
mandatory to restore optimal coronary perfusion, reduce angina 
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Note, data were presented in mean ± SD or n(%); OMT = optimal medical treatment; PCI = percutaneous coronary intervention.
Table 3. Correlation between clinical outcomes and SYNTAX score.
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Current guidelines strongly recommend CABG than PCI for patient with 
more complex lesion.1,5,6 However, in several circumstances such as: (1) 
the existence of comorbid disease; (2) advanced age; (3) frailty; (4) low 
life expectancy; (5) mobilization restriction that impede the rehabilita-
tion program; (6) low-quality graft; (7) severe spine and chest deformi-
ty; (8) porcelain aorta; or (9) chest radiation sequelae, CABG may be 
not appropriate.6 Stress, fear, or anxiety about the CABG procedure 
may be the reason for several patients to refuse that procedure.23 In 
those kinds of patients, PCI in CCS patients with SYNTAX score of more 
than 22 is reasonable because the restoration of optimal coronary is 
warranted. Our study was the first study assessing the benefit of OMT 
plus PCI over PCI alone in improving QoL in patients with SYNTAX 
score of more than 22s to the best of our knowledge. Prior studies such 
as the COURAGE trial and TIME trial did not use the SYNTAX score in 
their data analysis.17,18
 In this study, we did not find loss to follow-up because the 
patients who had lost to follow-up patients were excluded. Our study 
had several limitations. First, the SAQ assessment was conducted only 
in the end of study. Second, the small number of study participants. 
Third, our study follow-up period duration was not similar among the 
study participants. Due to those limitations, the randomized controlled 
trial (RCT) with larger participants, better design, and longer follow-up 
is needed.  
5. Conclusion
 Several important lessons could be obtained from our study. 
Myocardial revascularization by PCI improved the QoL in CCS patients 
treated with OMT. Second, OMT plus PCI improves physical limitation 
and angina stability. For patients with SYNTAX score of more than 22, 
OMT plus PCI was correlated with good QoL achievement.
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 Coronary artery disease (CAD) is a disease characterized by 
atherosclerotic plaque formation in the epicardial coronary arteries.1,2 It 
is well known as the leading cause of mortality around the world.2,3 
Annually, in Indonesia, at least 470,000 mortalities are estimated to be 
caused by CAD or stroke.4 The various clinical presentations can be 
caused by the dynamic nature of CAD. Generally, according to the 
clinical presentation, CAD can be classified into chronic coronary 
syndromes (CCS) and acute coronary syndromes (ACS).1 CCS in a new 
terminology proposed by the European Society of Cardiology (ESC) 
replacing stable CAD. The CCS is defined as the progressive atheroscle-
rotic plaque accumulation process accompanied by functional 
alteration in the coronary artery. It has replaced the old terminology 
stable CAD.1 The management of CCS includes lifestyle changes, 
optimal medical treatment (OMT), and myocardial revascularization.1,5
 Myocardial revascularization strategies in CAD include 
percutaneous coronary intervention (PCI) and coronary artery bypass 
graft (CABG) surgery.6 The purpose of myocardial revascularization in 
CCS includes: (1) myocardial ischemia elimination; (2) eliminate 
clinical manifestations; and (3) major adverse cardiovascular event 
(MACE) risk reduction.1,5,6 Revascularization strategy by PCI or CABG 
can be determined using the Synergy Between PCI With Taxus and 
CABG (SYNTAX) score.6 
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Background : The benefit of PCI to improve quality of life (QoL) in chronic coronary syndrome (CCS) is still 
unclear. 
Objectives : This study aimed to assess the benefit of percutaneous coronary intervention (PCI) in improving QoL 
among CCS patients receiving OMT.
Methods : We conducted a retrospective cohort study. CCS patients who underwent coronary angiography (CAG) 
and/or PCI were grouped into OMT plus PCI and OMT groups. The SYNTAX score was used to assess the 
complexity and severity of coronary artery lesions. The outcome measured was QoL assessed using Seattle 
Angina Questionnaire (SAQ) and rehospitalization.
Results: A total of 57 patients in the OMT plus PCI group and 49 patients in the OMT group were included. The 
percentage of patients with good QoL was higher in the OMT plus PCI group than OMT only group (64.5% vs. 
35.5%; p = 0.007). The OMT plus PCI group revealed a better activities of daily living (85.11 ± 12.46 vs. 12.46 
± 21.87; p = 0.014) and angina stability (84.32 ± 23.63 vs. 71.81 ± 27.89; p = 0.014) than OMT group. Among 
patients with SYNTAX scores of more than 22, achievement of good QoL was greater in the OMT plus PCI group 
than the OMT group (80.8% vs. 45.5%; p = 0.025).
Conclusion: PCI improved the QoL in CCS patients treated with OMT. Second, OMT plus PCI improves physical 
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